-
1مورد إلكتروني
مصطلحات الفهرس: acute kidney inflammation, unilateral ureter obstruction, FMS kinase inhibitor/cr [Drug Concentration], FMS kinase inhibitor/pk [Pharmacokinetics], FMS kinase inhibitor/pd [Pharmacology], KIT kinase inhibitor/pk [Pharmacokinetics], KIT kinase inhibitor/pd [Pharmacology], plx 647/cr [Drug Concentration], plx 647/pk [Pharmacokinetics], plx 647/pd [Pharmacology], KIT kinase inhibitor/cr [Drug Concentration], allodynia, animal cell, animal cell culture, animal tissue, area under the curve, arthritis, article, bone pain, cell activation, crystal structure, cytokine release, dose response, drug blood level, drug clearance, drug design, drug protein binding, drug selectivity, drug structure, drug targeting, macrophage, mast cell, mouse, nephritis, nonhuman, osteoclast, osteolysis, passive skin anaphylaxis, priority journal, rat, ureter obstruction, virus oncogene, interleukin 6/ec [Endogenous Compound], lipopolysaccharide, phosphotransferase inhibitor/cr [Drug Concentration], phosphotransferase inhibitor/pk [Pharmacokinetics], phosphotransferase inhibitor/pd [Pharmacology], Tumor necrosis factor alpha/ec [Endogenous Compound], unclassified drug, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/42649Test
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: acute kidney inflammation, unilateral ureter obstruction, FMS kinase inhibitor/cr [Drug Concentration], FMS kinase inhibitor/pk [Pharmacokinetics], FMS kinase inhibitor/pd [Pharmacology], KIT kinase inhibitor/pk [Pharmacokinetics], KIT kinase inhibitor/pd [Pharmacology], plx 647/cr [Drug Concentration], plx 647/pk [Pharmacokinetics], plx 647/pd [Pharmacology], KIT kinase inhibitor/cr [Drug Concentration], allodynia, animal cell, animal cell culture, animal tissue, area under the curve, arthritis, article, bone pain, cell activation, crystal structure, cytokine release, dose response, drug blood level, drug clearance, drug design, drug protein binding, drug selectivity, drug structure, drug targeting, macrophage, mast cell, mouse, nephritis, nonhuman, osteoclast, osteolysis, passive skin anaphylaxis, priority journal, rat, ureter obstruction, virus oncogene, interleukin 6/ec [Endogenous Compound], lipopolysaccharide, phosphotransferase inhibitor/cr [Drug Concentration], phosphotransferase inhibitor/pk [Pharmacokinetics], phosphotransferase inhibitor/pd [Pharmacology], Tumor necrosis factor alpha/ec [Endogenous Compound], unclassified drug, Article